Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-25-012241

Chief Scientific Officer acquired 192,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2025-02-11 Grant or award +74,000 1,074,666 D
Kidron Miriam Chief Scientific Officer 2025-02-11 Grant or award +52,000 1,126,666 D
Kidron Miriam Chief Scientific Officer 2025-02-11 Grant or award +66,667 1,193,333 D
Loading xslF345X05/ownership.xml…